|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 256.55 USD | +2.00% |
|
+0.28% | +12.18% |
| Capitalization | 37.39B 32.14B 30.11B 28.07B 51.84B 3,365B 56.38B 352B 136B 1,589B 140B 137B 5,811B | P/E ratio 2026 * |
24.5x | P/E ratio 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise value | 36.16B 31.09B 29.12B 27.14B 50.13B 3,255B 54.53B 341B 132B 1,537B 136B 133B 5,620B | EV / Sales 2026 * |
6.45x | EV / Sales 2027 * | 5.86x |
| Free-Float |
76.64% | Yield 2026 * |
0.94% | Yield 2027 * | 1.04% |
Last Transcript: ResMed, Inc.
| 1 day | +2.00% | ||
| 1 week | +0.28% | ||
| Current month | +0.28% | ||
| 1 month | +2.76% | ||
| 3 months | -7.40% | ||
| 6 months | +1.72% | ||
| Current year | +12.18% |
| 1 week | 237.62 |  | 257.98 |
| 1 month | 237.62 | | 258.09 |
| Current year | 199.92 | | 293.81 |
| 1 year | 199.92 | | 293.81 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 50.77 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 52 | 2013-02-28 |
Brett Sandercock
DFI | Director of Finance/CFO | 58 | 2005-12-31 |
Jim Ellis
CMP | Compliance Officer | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 77 | 2004-12-31 |
Mick Farrell
CHM | Chairman | 52 | 2023-01-24 |
Peter Farrell
CHM | Chairman | 82 | 1989-05-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.09% | 26 M€ | +11.73% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.00% | +0.28% | +6.27% | +17.83% | 37.39B | |
| -0.43% | -3.06% | +8.20% | +4.04% | 215B | |
| +1.18% | +0.32% | +4.53% | +116.04% | 204B | |
| -0.39% | -0.23% | -1.68% | -14.74% | 160B | |
| -0.20% | -4.00% | +8.27% | +115.94% | 145B | |
| +1.92% | +1.56% | -15.42% | -11.65% | 56.48B | |
| +0.48% | -0.55% | +20.49% | +19.26% | 50.02B | |
| -1.91% | -5.22% | +3.49% | -3.87% | 41.18B | |
| +3.56% | +6.84% | +5.19% | - | 38.93B | |
| +1.19% | -0.79% | -22.99% | -37.74% | 34.62B | |
| Average | +0.74% | -0.37% | +1.64% | +22.79% | 98.21B | |
| Weighted average by Cap. | +0.37% | -1.09% | +3.62% | +40.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.6B 4.82B 4.51B 4.2B 7.77B 504B 8.45B 52.77B 20.37B 238B 21.03B 20.58B 871B | 6.02B 5.17B 4.85B 4.52B 8.35B 542B 9.08B 56.7B 21.89B 256B 22.59B 22.11B 936B |
| Net income | 1.54B 1.32B 1.24B 1.15B 2.13B 138B 2.32B 14.46B 5.58B 65.27B 5.76B 5.64B 239B | 1.71B 1.47B 1.37B 1.28B 2.37B 154B 2.57B 16.08B 6.21B 72.55B 6.41B 6.27B 265B |
| Net Debt | -1.23B -1.06B -991M -923M -1.71B -111B -1.85B -11.59B -4.47B -52.29B -4.62B -4.52B -191B | -2.1B -1.8B -1.69B -1.57B -2.91B -189B -3.16B -19.76B -7.63B -89.16B -7.87B -7.7B -326B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 256.55 $ | +2.00% | 708,376 |
| 25-12-04 | 251.51 $ | +0.03% | 489,063 |
| 25-12-03 | 251.44 $ | +0.24% | 549,929 |
| 25-12-02 | 250.85 $ | +0.99% | 1,086,092 |
| 25-12-01 | 248.38 $ | -2.91% | 1,296,102 |
Delayed Quote Nyse, December 05, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition